Skip to content

Clinical trials

Phase 3 Carcinoma, Ovarian Epithelial trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Phase 3 Country / region: Italy Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20052
20061
20111
20161
20172
20181
20191
20203
20212
20221
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Active, not recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
European Organisation for Research and Treatment of Cancer - EORTC4
pharmaand GmbH3
ImmunoGen, Inc.2
AbbVie1
Amgen1
CanariaBio Inc.1
Daiichi Sankyo1
EBMT Solid Tumors Working Party1
Ente Ospedaliero Ospedali Galliera1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial25
Fallopian Tube Neoplasms17
Ovarian Neoplasms17
Neoplasms3
Peritoneal Neoplasms3
Recurrence3
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Embryonal1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.